Home » Topics » BioWorld

BioWorld
RSS

ISIS FILES IND FOR ANTISENSE DRUG

Jan. 31, 1992

T CELL COMPLETES DEAL WITH ASTRA

Jan. 31, 1992

IMMUNOMEDICS RAISES $28 MILLION

Jan. 31, 1992

CORVAS IPO RAISES $36 MILLION

Jan. 31, 1992

ANALYST DOWNGRADES U.S. BIOSCIENCE

Jan. 31, 1992

ANALYST RECOMMENDS IDEXX

Jan. 30, 1992

BAXTER PLANS BONE MARROW TRIALS

Jan. 30, 1992

IMMUNEX MARKETING DEAL

Jan. 30, 1992

ONCOR RAISES $31.5 MILLION IN SECONDARY

Jan. 30, 1992

PDL IPO BRINGS IN $52.5 MILLION

Jan. 30, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...